VectivBio

Orphomed

This biopharmaceutical company develops dimer therapeutics for patients suffering from gastrointestinal disorders, including irritable bowel syndrome with diarrhea.

Avexegen

This biopharmaceutical company develops peptide therapies to treat gastrointestinal disorders and restore gut health for patients with inflammatory conditions.

Noema Pharma

This company develops clinical-stage therapeutic products for patients with central nervous system disorders and orphan neurological conditions.

Mereo BioPharma

The company develops clinical-stage therapies for patients with rare diseases, including osteogenesis imperfecta and alpha-1 antitrypsin deficiency-associated lung disease.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Eton Pharmaceuticals

This company develops and commercialises prescription medicines to treat patients living with rare diseases.

PHVS

This company develops oral therapies to treat and prevent hereditary angioedema attacks for patients with rare diseases.

GondolaBio

This biopharmaceutical company develops clinical-stage and preclinical medicinal therapeutics for patients living with rare genetic diseases.